Journal article
Authors list: Richter, Manuel J.; Wan, Jun; Ghofrani, Hossein A.; Seeger, Werner; Gall, Henning; Rieth, Andreas; Tello, Khodr
Publication year: 2019
Journal: Pulmonary Circulation
Volume number: 9
Issue number: 3
ISSN: 2045-8932
eISSN: 2045-8940
Open access status: Gold
DOI Link: https://doi.org/10.1177/2045894019875342
Publisher: Wiley
Abstract:
The Breelib (TM) nebulizer was designed to reduce iloprost inhalation times for patients with pulmonary arterial hypertension (PAH). In 30 patients with PAH, rapid inhalation of iloprost 2.5 mu g using Breelib (TM) caused significant improvements in invasively measured afterload and cardiac index but not echocardiographic right ventricular strain during 30 min post-inhalation.
Citation Styles
Harvard Citation style: Richter, M., Wan, J., Ghofrani, H., Seeger, W., Gall, H., Rieth, A., et al. (2019) Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study, Pulmonary Circulation, 9(3), Article 2045894019875342. https://doi.org/10.1177/2045894019875342
APA Citation style: Richter, M., Wan, J., Ghofrani, H., Seeger, W., Gall, H., Rieth, A., & Tello, K. (2019). Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study. Pulmonary Circulation. 9(3), Article 2045894019875342. https://doi.org/10.1177/2045894019875342
Keywords
AEROSOL DELIVERY; aerosol drug therapy; hemodynamics; INHALED ILOPROST; prostanoid; Pulmonary hypertension; right ventricular function
